about
Ionic liquid-functionalized magnetic nanostructures as an efficient catalyst for the synthesis of 6H-chromeno[4,3-b]quinolin-6-ones.Design, synthesis, molecular modeling and anticholinesterase activity of benzylidene-benzofuran-3-ones containing cyclic amine side chain.Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors.Synthesis and biological evaluation of novel imidazopyrimidin-3-amines as anticancer agents.Design, synthesis, in vitro cytotoxic activity evaluation, and apoptosis-induction study of new 9(10H)-acridinone-1,2,3-triazoles.Synthesis and cytotoxic activity of novel poly-substituted imidazo[2,1-c][1,2,4]triazin-6-amines.Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents.A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease.Potent acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to 1,2,3-triazole derivatives.Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease.Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.Design, synthesis, pharmacological evaluation, and docking study of new acridone-based 1,2,4-oxadiazoles as potential anticonvulsant agents.Discovery of imidazopyridines containing isoindoline-1,3-dione framework as a new class of BACE1 inhibitors: Design, synthesis and SAR analysis.Novel Tacrine-Based Pyrano[3',4':5,6]pyrano[2,3-b]quinolinones: Synthesis and Cholinesterase Inhibitory Activity.Synthesis and anticholinesterase activity of new substituted benzo[d]oxazole-based derivatives.Quinoline-based imidazole-fused heterocycles as new inhibitors of 15-lipoxygenase.Novel quinazolin-4(3H)-one linked to 1,2,3-triazoles: Synthesis and anticancer activity.Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors.Design, Synthesis, Biological Evaluation, and Docking Study of Acetylcholinesterase Inhibitors: New Acridone-1,2,4-oxadiazole-1,2,3-triazole Hybrids.Synthesis and Evaluation of Chroman-4-One Linked to N-Benzyl Pyridinium Derivatives as New Acetylcholinesterase Inhibitors.Synthesis and structure-activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors.Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids.Synthesis of novel chromenones linked to 1,2,3-triazole ring system: Investigation of biological activities against Alzheimer's disease.New tacrine-derived AChE/BuChE inhibitors: Synthesis and biological evaluation of 5-amino-2-phenyl-4H-pyrano[2,3-b]quinoline-3-carboxylates.Phthalimide-Derived N-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents.Synthesis of novel fused quinazolinone derivatives.Imidazo[2,1-b]thiazole derivatives as new inhibitors of 15-lipoxygenase.Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking studyDesign, synthesis and anti-Alzheimer's activity of novel 1,2,3-triazole-chromenone carboxamide derivativesNovel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking studyBiology-Oriented Drug Synthesis (BIODS) Approach towards Synthesis of Ciprofloxacin-Dithiocarbamate Hybrids and Their Antibacterial Potential both in Vitro and in SilicoDesign, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetesNew 6-amino-pyrido[2,3- d ]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α -glucosidase inhibition, molecular modeling and kinetic studyLarge-scale virtual screening for the identification of new Helicobacter pylori urease inhibitor scaffoldsSynthesis and anti-leishmanial activity of 5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-amines containing N-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl] moietiesCombined isocyanide-based multi-component Ullmann-type reaction: an efficient access to novel nitrogen-containing pentacyclic compoundsN-(2-(Piperazin-1-yl)phenyl)arylamide Derivatives as β-Secretase (BACE1) Inhibitors: Simple Synthesis by Ugi Four-Component Reaction and Biological EvaluationSynthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffoldSynthesis, biological evaluation and docking study of 3-aroyl-1-(4-sulfamoylphenyl)thiourea derivatives as 15-lipoxygenase inhibitors
P50
Q36364719-99E52D19-7C0F-4BB8-BE75-8D024D33CFA0Q38686098-E144EBE6-DD19-4F40-8363-CA1AEFE56F96Q38730309-90F17C02-A789-43A4-8A1D-D62AEC86FE9DQ38730486-01E27A94-F855-4D3E-8E95-41F8054D09D7Q38853487-9D0CB45F-74CC-4746-945A-FE20AD6570FAQ38917296-EB3C6FDD-7FFE-4597-8E83-E2E647A48F59Q38957118-8A5A06E5-0619-48DC-8FBD-A354C9A40E13Q39017079-5D4DFCD2-06BB-4EAE-8372-C1482B8F774BQ44148006-0C6B451B-71C9-4A2A-A4C1-0ED70CB668E6Q47436561-2F5A6D87-8DB0-40D7-96C9-238D5790DAB8Q50110373-2E6B57C5-4A64-4F48-8F2C-3E012D9C611EQ50110388-A8012C4F-5562-4B1E-B2C4-A036D36F14B6Q50230845-BD32F9AD-5368-410F-A4CB-7D050B664E62Q50879807-0A8F4E09-2AED-445B-B2D5-EA054090A233Q51290528-6D43ADF8-17FC-4DDF-ACCE-C5A197B2B17EQ51318046-3E0FFB1D-8DEB-4B88-B232-69F114D1E4D8Q51636681-9582C38C-DBFC-459E-9404-24CAA7C634FCQ52594647-4E311429-3A7A-49AE-A8BF-1C544FB9A90FQ53361694-5175ABA7-3D89-4CB3-B86E-906E0EB429D4Q53365323-147B6E36-D2F6-4173-B239-8AAAE8D69B88Q53366348-204F807B-5331-4C36-9FDB-950490B018D9Q53368014-71A1DE37-0842-45ED-B5A4-A0B0AD97FF3DQ53378645-4A44BD12-4EB8-4AF7-8DBC-6E4F4D729EDFQ53384400-FB251B84-F080-49FF-A2CF-8479C825910EQ53386621-7C4620D9-3862-4047-8627-EC0F547EED36Q53487204-F9E00989-F995-4734-BC3C-821993936A28Q53606461-B28741D0-CC0F-423A-A078-122E46E218ECQ54481955-EAD214DB-36A0-4A6E-AE4E-2D5DA260D0E8Q58571818-459B3AC6-4652-4A5D-A0EA-376B0178C3BBQ58589735-6AA816AA-EEC6-4E72-A44F-E4BD5F2BF4EEQ58600396-8963DD3C-0B13-4831-BC18-34F94BBE0C5FQ62104703-DF49CCEF-7E5C-4C3A-9E3E-46F3F98FAE9BQ62104705-0C57D596-E805-462F-A2AF-08975DA14C71Q62104706-DEA122EF-B08B-47BE-AA8F-A5AE0FC9BE51Q82797003-296FC5F4-7BD8-4CD7-895C-4158FF8A15DAQ83452367-8A410571-8623-4E5C-BD37-5A1627EDD622Q85691568-3260613B-4BEF-4D57-8A5A-0C5DD8AB344DQ86954750-0BE1CFF7-B1C5-472A-8DED-FFCC9E8EB233Q87063978-68E50C4D-A1A8-4C30-A0F1-4939B459DFC0Q88074769-B6C86C53-68A9-4C0E-808F-1AF6215892AD
P50
description
researcher (ORCID 0000-0002-8007-2543)
@en
name
Mohammad Mahdavi
@en
type
label
Mohammad Mahdavi
@en
prefLabel
Mohammad Mahdavi
@en
P31
P496
0000-0002-8007-2543